| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.6 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |